Read the original article here.  Halifax-based Adaptiiv has announced major new clients in Hong Kong and the U.S. as the young medical technology company expands its customer base to seven countries. The company – which uses 3D printing technology to improve radiation therapy in cancer treatment – said Monday it had signed a deal to sell its…

Read the original article here. Halifax, Nova Scotia, October 3, 2018 – Sona Nanotech Inc. (CSE: SONA) (“Sona” or the “Company”) is pleased to announce that the Canadian Securities Exchange (CSE) has approved the Company’s application to list its common shares on the CSE.  Effective October 4, 2018, the Company’s shares will commence trading on…

See original job posting here Company Overview Solid State Pharma Inc. (SSPI) is a leader in the delivery of crystallization engineering services including screening and selection of polymorphs, co-crystals, salts, and crystallization process development and optimization. SPPI has experienced great success with the workflows that have been developed by combining fundamentals of crystallization and solid…

Athletigen teams up with CrossFit leader MobilityWOD   HALIFAX – September 17, 2018 – Athletigen Technologies, Inc. has announced the launch of its Optimum Movement and Recovery report, a DNA product that was created in partnership with Dr. Kelly Starrett and his company MobilityWOD.   The report uses 23andMe, AncestryDNA, or Athletigen DNA data, for…

Read the original article here.  Appili Therapeutics, a Halifax-based drug development company, has appointed its first ever Chief Scientific Officer. Armand Balboni, the new CSO, will be responsible for the company’s clinical and scientific strategy as well as steering its programs through regulatory and pre-commercialization processes. “Armand’s medical science, business, and military experience, including his particular…

See the original post here.  HALIFAX, Nova Scotia, October 1, 2018 – Appili Therapeutics Inc. (the “Company” or “Appili”), a biopharmaceutical company focused on drug development for infectious diseases, has named Dr. Armand Balboni as its first Chief Scientific Officer (CSO). In his new role with Appili, Dr. Balboni is responsible for the Company’s clinical and scientific strategy, with a particular emphasis on overseeing the scientific aspects of Appili’s government and industry…

September 26, 2018 [OTTAWA] – BIOTECanada is pleased to announce the 2018 winners of the Gold Leaf Awards which annually highlight innovation and entrepreneurship within the Canadian biotechnology industry. This national celebration of the Canadian industry represents an outstanding collection of companies and individuals who have helped lead the industry throughout 2018. “The remarkable individuals…

Read original article here   Over the last several years, the topic of mental health has come to the forefront. What was once as a topic veiled in shame and secrecy is not being discussed openly, and for the better. Whether it’s in the workplace, educational institutions, or at alone at home, businesses and startups worldwide are…

For Immediate Release   Chelation Partners Presents Data on Their Lead Non-Antibiotic Anti-Infective Compound at the 2018 Kansas City Animal Health Investment Forum.   Halifax, NS, Canada, September 12, 2018 – Chelation Partners Inc. (CPI), a Halifax based life sciences company, has presented interim results from a field study comparing a clinical standard of care…

September 11, 2018 (Halifax, N.S.) Nature’s Way and Natural Products Canada have signed an agreement to co-invest in innovative natural health product opportunities in Canada. The output of this partnership will continue to feed consumers’ needs for natural product solutions, a category that is already growing +5% in Canada.   “We are very excited to…

2015 © Copyright - Bionova